
The availability of safe and partially effective disease zzso therapies zzso changes in how zzso monitor patients with zzso zzso multiple sclerosis zzso zzso need to make the diagnosis of zzso as soon as possible to be able to initiate therapy early in the course of zzso In deciding whom to treat, zzso should consider information on disease activity and burden acquired from the zzso history and examination and magnetic resonance imaging zzso Patients not on a disease zzso therapy should undergo yearly clinical assessments and periodic cerebral zzso to monitor for changes in disease zzso Patients on disease zzso therapy should undergo regular clinical assessments to monitor for zzso and disease zzso zzso zzso scanning may also be useful in assessing patients on therapy, particularly when considering changes in zzso 

